Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study.

RECOMMENDED

Lung Cancer

Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line - Results from the prospective German TLK cohort study

Lung Cancer.

Steffens CC, Elender C, Hutzschenreuter U, Dille S, Binninger A, Spring L, Jänicke M, Marschner N, TLK-Group (Tumour Registry Lung Cancer)

doi: 10.1016/j.lungcan.

RECOMMENDED

Tuberculosis

Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis

Am J Respir Crit Care Med.

Dheda K, Lenders L, Magombedze G, Srivastava S, Raj P, Arning E, Ashcraft P, Bottiglieri T, Wainwright H, Pennel T, Linegar A, Moodley L, Pooran A, Pasipanodya JG, Sirgel FA, van Helden PD, Wakeland E, Warren RM, Gumbo T

doi: 10.1164/rccm.

RECOMMENDED

Tuberculosis

Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis

★ 2 Recommended by Dr Martin Frey, Faculty Member

Lancet.

Bisson GP, Bastos M, Campbell JR, Bang D, Brust JC, Isaakadis P, Lange C, Menzies D, Migliori GB, Pape JW, Palmero D, Baghei P, Tabarsi P, Viiklepp P, Vilbrun S, Walsh J, Marks SM

doi: 10.1016/S0140-6736(20)31316-7.

RECOMMENDED

Pulmonary Hypertension

Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study

★ 2 Recommended by Dr Martin Frey, Faculty Member

Lancet Respir Med.

Maron BA, Brittan EL, Hess E, Waldo SW, Barón AE, Huang S, Goldstein RH, Assad T, Wertheim BM, Alba GA, Leopold JA, Olschewski H, Galiè N, Simonneau G, Kovacs G, Tedford RJ, Humbert M, Choudhary G

doi: 10.1016/S2213-2600(20)30317-9.

RECOMMENDED

Tuberculosis

Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review

Eur Respir J.

Law S, Daftary A, O'Donnell M, Padayatchi N, Calzavara L, Menzies D

doi: 10.1183/13993003.

Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis

Lancet Respir Med.

Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien JY, Cox H, Dedicoat M, Erkens C, Escalante P, Falzon D, Garcia-Prats AJ, Gegia M, Gillespie SH, Glynn JR, Goldberg S, Griffith D, Jacobson KR, Johnston JC, Jones-López EC, Khan A, Koh WJ, Kritski A, Lan ZY, Lee JH, Li PZ, Maciel EL, Galliez RM, Merle CSC, Munang M, Narendran G, Nguyen VN, Nunn A, Ohkado A, Park JS, Phillips PPJ, Ponnuraja C, Reves R, Romanowski K, Seung K, Schaaf HS, Skrahina A, Soolingen DV, Tabarsi P, Trajman A, Trieu L, Banurekha VV, Viiklepp P, Wang JY, Yoshiyama T, Menzies D

doi: 10.1016/S2213-2600

RECOMMENDED

Further Publications

Multimorbidity and its relationship with long-term outcomes following critical care discharge: a prospective cohort study

★ 1 Recommended by Dr Martin Frey, Faculty Member

Chest

McPeake J, Quasim T, Henderson P, Leyland AH, Lone NI, Walters M, Iwashyna TJ, Shaw M

doi: 10.1016/j.chest.2021.05.069

RECOMMENDED

Tuberculosis

Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

N Engl J Med.

Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, Mendel CM, Egizi E, Moreira J, Timm J, McHugh TD, Wills G, Bateson A, Hunt R, Van Niekerk C, Li M, Olugbosi M, Spigelman M

doi: 10.1056/NEJMoa1901814.

RECOMMENDED

Tuberculosis

Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Lancet Respir Med.

Lan Z, Ahmad N, Baghaei P, Barkane L, Benedetti A, Brode SK, Brust JCM, Campbell JR, Chang VWL, Falzon D, Guglielmetti L, Isaakidis P, Kempker RR, Kipiani M, Kuksa L, Lange C, Laniado-Laborín R, Nahid P, Rodrigues D, Singla R, Udwadia ZF, Menzies D, Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment 2017.

doi: 10.1016/S2213-2600(20)30047-3.

Related content

Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line - Results from the prospective German TLK cohort study

Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis

Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis

Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study

Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review

Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis

Multimorbidity and its relationship with long-term outcomes following critical care discharge: a prospective cohort study

Bedaquiline, pretomanid and linezolid for treatment of extensively drug resistant, intolerant or non-responsive multidrug resistant pulmonary tuberculosis

Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis